This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2018 Jan;59(1):213-217.

doi: 10.1007/s12020-017-1270-0. Epub 2017 Mar 6.

Palbociclib inhibits proliferation of human adrenocortical tumor cells

Affiliations

Affiliations

¹ Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, V.le Europa 11, 25123, Brescia, Italy.
² Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia at Asst Spedali Civili di Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.
³ Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at Asst Spedali Civili di Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.
⁴ Section of Oncology and Experimental Immunology, Department of Molecular and Translational Medicine, University of Brescia, V.le Europa 11, 25123, Brescia, Italy.
⁵ Internal Medicine 1, Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, Regione Gonzole 10, 10043, Orbassano, Italy.
⁶ Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at Asst Spedali Civili di Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy. alfredo.berruti@gmail.com.

PMID: 28265858
DOI: 10.1007/s12020-017-1270-0

Palbociclib inhibits proliferation of human adrenocortical tumor cells

Chiara Fiorentini et al. Endocrine. 2018 Jan.

. 2018 Jan;59(1):213-217.

doi: 10.1007/s12020-017-1270-0. Epub 2017 Mar 6.

Authors

Affiliations

¹ Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, V.le Europa 11, 25123, Brescia, Italy.
² Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia at Asst Spedali Civili di Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.
³ Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at Asst Spedali Civili di Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.
⁴ Section of Oncology and Experimental Immunology, Department of Molecular and Translational Medicine, University of Brescia, V.le Europa 11, 25123, Brescia, Italy.
⁵ Internal Medicine 1, Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, Regione Gonzole 10, 10043, Orbassano, Italy.
⁶ Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia at Asst Spedali Civili di Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy. alfredo.berruti@gmail.com.

PMID: 28265858
DOI: 10.1007/s12020-017-1270-0

No abstract available

PubMed Disclaimer

References

1. Endocr Relat Cancer. 2005 Sep;12(3):657-66 - PubMed
1. Clin Cancer Res. 2014 Jul 1;20(13):3379-83 - PubMed
1. J Clin Endocrinol Metab. 2013 Oct;98(10):4080-8 - PubMed
1. Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8 - PubMed
1. Pharmacol Res. 2016 May;107:249-275 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

IG17678/AIRC/International

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations